In early 2014, I envisioned an opportunity to provide educational materials that more closely aligned to individuals affected by chronic obstructive pulmonary disease (COPD), their caregivers, and family members. After extensive discussions, I commissioned James Taylor, an experienced website designer [http://www.webhed.com] to create this website.
My Vision – to provide practical and current information that positively affects the daily lives of those with COPD and their families.
This website was launched in June 2014 and has three thematic topics:
1. COPD news – updates on recent publications in the medical journals, presentations at national respiratory conferences, and announcements about medications for COPD approved by the US Food and Drug Administration and made available by pharmaceutical companies
2. Real FAQs – questions submitted by those with COPD, caregivers, and family members are answered
3. Videos – about three individuals who have COPD and continue to lead active lives.
I have complete control of the contents of the website. No financial support has been provided for the development or operation of this website by any business or organization.
During the years 2015-2017, I received payments for the following activities: Advisory Board – AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan, Novartis, Sunovion, and Theravance; Royalties – CRC Press for Dyspnea, 3rd Edition, published in 2014; Salem Media Group for COPD: Answers to Your Questions, published in 2015; MAPI Research Trust and pharmaceutical companies for use of the baseline and transition dyspnea indexes in clinical trials. Speaker bureau – Boehringer Ingelheim, Grifols, and Sunovion.
Donald A. Mahler, M.D.
Dr. Mahler is Emeritus Professor of Medicine at Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. Since October 2014, he works as a pulmonary physician at Valley Regional Hospital in Claremont, New Hampshire, where he is Director of Respiratory Services. To schedule an appointment with Dr. Mahler, call the Kane Center at Valley Regional Hospital 603 542-6777. Fax number: 603 542-1927.
Dr. Mahler has written/edited four books on Dyspnea. Dyspnea is the medical word for shortness of breath or breathing difficulty.
- Dyspnea. Futura Publishing Company, Inc., 1990
- Dyspnea. Marcel Dekker, Inc., 1998
- Dyspnea: Mechanisms, Measurement, and Management, 2nd Edition, Taylor & Francis Group, 2005, co-edited with Denis E. O’Donnell
- Dyspnea: Mechanisms, Measurement, and Management, 3rd Edition, CRC Press, 2014, co-edited with Denis E. O’Donnell.
In collaboration with the late Dr. Alvin Feinstein, Dr. Mahler developed the Baseline and Transition Dyspnea Indexes (BDI/TDI). These questionnaires measure the impact of breathing difficulty related to activities of daily living. They have been used widely in clinical studies involving patients with COPD, and have been translated into over 80 languages. The BDI/TDI questionnaires are available for use from MAPI Research Institute in Lyon, France. http://mapi-trust.org/questionnaires/bdi-tdi/
Dr. Mahler has been selected by peers as one of the Best Doctors in America® for 2017-2018. Being named a Best Doctor recognizes about 4% of US doctors from whom other doctors would seek care. www.bestdoctors.com
In 2017 Dr. Mahler was invited to give the Middleton Lecture at the University of Texas Medical Branch, Galveston, TX
COPD educational video seriesJanuary 28, 2015
A series of six educational videos about COPD are posted. These videos feature three individuals who are living with COPD with a positive message about “staying active.” The videos were sponsored by the American Thoracic Society and have been shown in major US cities as public service announcements. The videos are:
November 6, 2014
Dr. Mahler was the 2014 recipient of Breathe New Hampshire’s Robert B. Kerr Award. The Kerr Award is awarded annually to a New Hampshire person who has consistently demonstrated a selfless professional or personal commitment to furthering lung health in the region for five or more years. Considerations include courage of conviction, creativity, innovation, and pioneering approaches to improving respiratory health.